|
|
40
|
|
|
BEMABIX 25MG/ML INJ (ABB/PHA) BEVACIZUMAB
|
|
|
4ML VIAL
|
|
|
C
|
|
|
856.27
|
|
|
25MG/ML
|
|
|
0
|
|
|
2022-04-01
|
|
|
2024-03-31
|
|
|
|
|
|
|
|
|
|
|
|
0
|